JP2008534558A - ピペリジン置換体 - Google Patents

ピペリジン置換体 Download PDF

Info

Publication number
JP2008534558A
JP2008534558A JP2008503525A JP2008503525A JP2008534558A JP 2008534558 A JP2008534558 A JP 2008534558A JP 2008503525 A JP2008503525 A JP 2008503525A JP 2008503525 A JP2008503525 A JP 2008503525A JP 2008534558 A JP2008534558 A JP 2008534558A
Authority
JP
Japan
Prior art keywords
alkyl
alkoxy
methoxy
propyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008503525A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008534558A5 (enExample
Inventor
ヘーロルト，ペーター
マー，ロベルト
チンケ，ヴィンチェンツォ
マルツィ，クリスティアーネ
シュトゥッツ，シュテファン
イェラコビッチ，スティエパン
ホリンガー，フランク
コンテアティス，ゼノン・ディー
ラジントン，ジェニファー・エル
クィルムバッハ，ミヒャエル
ストヤノビッチ，アレクサンダー
ベーンケ，ディルク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Speedel Experimenta AG
Original Assignee
Speedel Experimenta AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Speedel Experimenta AG filed Critical Speedel Experimenta AG
Publication of JP2008534558A publication Critical patent/JP2008534558A/ja
Publication of JP2008534558A5 publication Critical patent/JP2008534558A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
JP2008503525A 2005-03-31 2006-03-30 ピペリジン置換体 Pending JP2008534558A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66655605P 2005-03-31 2005-03-31
US75085305P 2005-12-16 2005-12-16
PCT/EP2006/061197 WO2006103277A2 (en) 2005-03-31 2006-03-30 2 , 4 , 5-substituted piperidines as renin inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008069369A Division JP2008201787A (ja) 2005-03-31 2008-03-18 ピペリジン置換体

Publications (2)

Publication Number Publication Date
JP2008534558A true JP2008534558A (ja) 2008-08-28
JP2008534558A5 JP2008534558A5 (enExample) 2009-05-14

Family

ID=36586065

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008503525A Pending JP2008534558A (ja) 2005-03-31 2006-03-30 ピペリジン置換体
JP2008069369A Pending JP2008201787A (ja) 2005-03-31 2008-03-18 ピペリジン置換体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008069369A Pending JP2008201787A (ja) 2005-03-31 2008-03-18 ピペリジン置換体

Country Status (13)

Country Link
US (2) US20100029628A1 (enExample)
EP (1) EP1863803B1 (enExample)
JP (2) JP2008534558A (enExample)
AR (2) AR055756A1 (enExample)
AT (1) ATE479681T1 (enExample)
BR (2) BRPI0621969A2 (enExample)
CA (1) CA2601702A1 (enExample)
DE (1) DE602006016573D1 (enExample)
IL (2) IL186130A0 (enExample)
PL (1) PL1863803T3 (enExample)
PT (1) PT1863803E (enExample)
TW (2) TW200716622A (enExample)
WO (1) WO2006103277A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005020314D1 (de) 2004-08-25 2010-05-12 Actelion Pharmaceuticals Ltd Bicyclononen-derivate als renin-inhibitoren
TW200716622A (en) * 2005-03-31 2007-05-01 Speedel Experimenta Ag Substituted piperidines
MX2007014722A (es) 2005-05-27 2008-02-15 Actelion Pharmaceuticals Ltd Nuevos derivados de amida de acido piperidin carboxilico.
GB0514203D0 (en) 2005-07-11 2005-08-17 Novartis Ag Organic compounds
CN102516241B (zh) 2006-05-19 2015-07-29 艾伯维巴哈马有限公司 Cns活性的稠合的双环杂环取代的氮杂双环烷烃衍生物
CN101448824A (zh) * 2006-06-08 2009-06-03 斯皮德尔实验股份公司 2,5-双基取代的哌啶
TW200821303A (en) * 2006-08-08 2008-05-16 Speedel Experimenta Ag Organic compounds
EP1958634A3 (en) * 2007-02-14 2008-09-24 Speedel Experimenta AG Substituted piperidines as inhibitors of beta-secretase, cathepsin D, plasmepsin II and/or HIV protease
TW200922596A (en) * 2007-10-25 2009-06-01 Speedel Experimenta Ag 4,4-disubstituted piperidines
AR069145A1 (es) * 2007-11-02 2009-12-30 Speedel Experimenta Ag Piperidinas 4,4- disusutituidas, uso del compuesto en la produccion de un medicamento, un producto farmaceutico en base al compuesto y un metodo de prevencion de enfermedades
KR20100095605A (ko) 2007-12-19 2010-08-31 다이닛본 스미토모 세이야꾸 가부시끼가이샤 바이시클릭 헤테로시클릭 유도체
CA2714347A1 (en) 2008-02-08 2009-08-13 Novartis Ag Substituted piperidines as renin inhibitors
WO2009098276A1 (en) * 2008-02-08 2009-08-13 Novartis Ag Substituted piperidines as renin inhibitors
EA020853B1 (ru) 2008-05-05 2015-02-27 Мерк Кэнэда Инк. 3,4-замещенные пиперидиновые производные в качестве ингибиторов ренина
EP2163245A1 (en) 2008-09-10 2010-03-17 Novartis Ag Renin inhibitors for the treatment of psoriasis
US8389731B2 (en) * 2009-05-15 2013-03-05 Northwestern University Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthase
KR20120109292A (ko) 2009-06-24 2012-10-08 다이닛본 스미토모 세이야꾸 가부시끼가이샤 Ｎ-치환-시클릭 아미노 유도체
JP2018502778A (ja) * 2015-01-09 2018-02-01 ジェイ．ダブリュ． スピーカー コーポレイション 車両用の追跡及び照明システム及び方法
DE102015013191A1 (de) * 2015-10-10 2017-04-13 Daimler Ag Verfahren zum Betrieb einer Leuchteinheit und Leuchteinheit

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002543072A (ja) * 1999-04-27 2002-12-17 エフ．ホフマン−ラ ロシュ アーゲー レニン阻害剤
JP2002543063A (ja) * 1999-04-27 2002-12-17 エフ．ホフマン−ラ ロシュ アーゲー レニンインヒビター
WO2004089903A1 (en) * 2003-04-10 2004-10-21 Warner-Lambert Company Llc Piperidine derivatives as renin inhibitors for the treatment of hypertension
JP2008201787A (ja) * 2005-03-31 2008-09-04 Speedel Experimenta Ag ピペリジン置換体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997009311A1 (de) * 1995-09-07 1997-03-13 F. Hoffmann-La Roche Ag Neue 4-(oxyalkoxyphenyl)-3-oxy-piperidine zur behandlung von herz- und niereninsuffizienz

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002543072A (ja) * 1999-04-27 2002-12-17 エフ．ホフマン−ラ ロシュ アーゲー レニン阻害剤
JP2002543063A (ja) * 1999-04-27 2002-12-17 エフ．ホフマン−ラ ロシュ アーゲー レニンインヒビター
WO2004089903A1 (en) * 2003-04-10 2004-10-21 Warner-Lambert Company Llc Piperidine derivatives as renin inhibitors for the treatment of hypertension
JP2008201787A (ja) * 2005-03-31 2008-09-04 Speedel Experimenta Ag ピペリジン置換体

Also Published As

Publication number Publication date
WO2006103277A2 (en) 2006-10-05
US7687495B2 (en) 2010-03-30
BRPI0608758A2 (pt) 2009-07-07
PL1863803T3 (pl) 2011-02-28
IL186130A0 (en) 2008-01-20
AR055756A1 (es) 2007-09-05
JP2008201787A (ja) 2008-09-04
ATE479681T1 (de) 2010-09-15
EP1863803A2 (en) 2007-12-12
PT1863803E (pt) 2010-11-18
WO2006103277A3 (en) 2006-12-28
TW200833687A (en) 2008-08-16
DE602006016573D1 (de) 2010-10-14
BRPI0621969A2 (pt) 2011-07-19
IL189429A0 (en) 2008-06-05
CA2601702A1 (en) 2006-10-05
AR065188A2 (es) 2009-05-20
TW200716622A (en) 2007-05-01
EP1863803B1 (en) 2010-09-01
US20100029628A1 (en) 2010-02-04
US20080171748A1 (en) 2008-07-17

Similar Documents

Publication Publication Date Title
JP2008201787A (ja) ピペリジン置換体
JP4842262B2 (ja) レニン阻害剤としてのピペリジン誘導体
US20120115859A1 (en) 3,4,5-substituted piperidines as renin inhibitors
CN101370806A (zh) 取代的4-苯基哌啶
JP2009539806A (ja) ２，５−二置換ピペリジン
CN101151263A (zh) 作为肾素抑制剂的取代的哌啶
US20100256146A1 (en) Trisubstituted piperidines
CN101151262B (zh) 取代的哌啶
KR20100097731A (ko) 레닌 억제제로서의 삼치환된 피페리딘
EA048563B1 (ru) Производные альфа-d-галактопиранозида
CN101151247A (zh) 作为肾素抑制剂的3,4,5-取代哌啶
EP1958634A2 (en) Substituted piperidines as inhibitors of beta-secretase, cathepsin D, plasmepsin II and/or HIV protease
EP1897879A2 (en) 2,4,5 substituted piperidines as renin inhibitors
HK1116163A (en) 2,4,5 substituted piperidines as renin inhibitors

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090327

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090327

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20111116

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111213

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120612